UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934.
Date of Report: May 10, 2017
(Date of earliest event reported)
BioVie Inc.
(Exact name of registrant as specified in its charter)
| Nevada | 333-190635 | 46-2510769 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) | ||
| 100 Cummings Center, Suite 247-C, Beverly, MA | 01915 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(312) 283-5793
(Registrant’s telephone number, including area code)
Nanobiotics, Inc.
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02(d) Election of Directors.
On May 10, 2017, the Board of Directors of BioVie Inc. ("BioVie") elected Dr. Hari Kumar as an independent member of BioVie's Board of Directors. Dr. Kumar is an accomplished executive in the biopharmaceutical industry, with experience in BioVie's primary therapeutic area, liver disease, and a strong track record of building multiple successful life sciences companies.
-1-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: May 15, 2017 | BIOVIE INC. | ||||||||
| By: | /s/ Jonathan Adams | ||||||||
| Jonathan Adams | |||||||||
| Chief Executive Officer | |||||||||
-2-